drugset / Trial / NCT03386032

8-Week Atopic Dermatitis (AD) Treatment Study

NCT03386032

Phase 3 Completed 65 enrolled Procter and Gamble
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a study to investigate the clinical effectiveness of the Sponsor's experimental cream treatment on eczema as measured by visual grading of SCORAD (scoring of atopic dermatitis).

Timeline

Start
2017-11-27
Primary completion
2018-08-18
Completion
2018-08-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desonide Small molecule 0.05 % Topical
Subject Investigational OTC Cream Unknown Topical

Indications